Clinical Trial Update: Precision Biomarkers to Detect Brain Injury in Active-Duty United States Special Operations Forces With Repeated Blast Exposure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating precision biomarkers to detect traumatic brain injury in active-duty military personnel with repeated blast exposure. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Blast Injury | Phase 2 | Status: RECRUITING